
GNE-049
CAS No. 1936421-41-8
GNE-049 ( GNE049 | GNE 049 )
产品货号. M13034 CAS No. 1936421-41-8
GNE-049 (GNE049) 是一种有效的、选择性的、口服的 CBP/p300 bromodomain 抑制剂,生化 IC50 分别为 1.1/2.3 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥4236 | 有现货 |
![]() ![]() |
50MG | ¥18468 | 有现货 |
![]() ![]() |
100MG | ¥26487 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称GNE-049
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述GNE-049 (GNE049) 是一种有效的、选择性的、口服的 CBP/p300 bromodomain 抑制剂,生化 IC50 分别为 1.1/2.3 nM。
-
产品描述GNE-049 (GNE049) is a potent, selective, orally available inhibitor of CBP/p300 bromodomain with biochemical IC50 of 1.1/2.3 nM, respectively; displays 3,850-fold selectivity over BRD4; shows excellent potency (12 nM) in a BRET cellular assay and inhibits the expression of MYC with EC50 of 14 nM in MV-4-11 cells; demonstrates significant dose-dependent inhibition of AR signaling and PC proliferation in vitro and in vivo.
-
体外实验GNE-049 is selected for further profiling as it has the best balance ofliver microsomes (LM) stability, selectivity, and cellular potency GNE-049 has excellent potency in the BRET cellular assay and, in an orthogonal measure of the target engagement, GNE-049 is shown to inhibit the expression of MYC (MV4-11 cell line) with an EC50 of 14 nM.
-
体内实验GNE-049 demonstrates acceptable PK in mouse, rat, dog, and monkey. Determination of potency versus a selection of bromodomains revealed that GNE-049 is selective for CBP/P300 and, importantly, quite selective (3820-fold) over BRD4(1). GNE-049 is further evaluated in a rat single dose (30-250 mg/kg QD) toxicokinetic study. Adverse central nervous system (CNS)-related signs (e.g., marked hyperactivity and vocalization) are observed in several of the rats at the 250 mg/kg dose level. Furthermore, at the 250 mg/kg dose level, the ratio of the unbound drug concentration in brain to unbound drug concentration in plasma (Kp,uu) 3 h post dose is determined to be 0.43, indicating that GNE-049 is penetrating into the CNS and potentially resulting in the observed toxicity.
-
同义词GNE049 | GNE 049
-
通路Chromatin/Epigenetic
-
靶点Bromodomain
-
受体Bromodomain
-
研究领域——
-
适应症——
化学信息
-
CAS Number1936421-41-8
-
分子量510.59
-
分子式C27H32F2N6O2
-
纯度>98% (HPLC)
-
溶解度DMSO : 100 mg/mL 195.86 mM
-
SMILESCC(N1CCC(N(C2COCC2)N=C3N4CCCC5=C4C=C(C(F)F)C(C6=CN(C)N=C6)=C5)=C3C1)=O
-
化学全称1-(3-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Jin L, et al. Cancer Res. 2017 Aug 17. pii: canres.0314.2017.
产品手册




关联产品
-
BET-BAY 002
BET-BAY 002 是一种有效的 BET 溴结构域抑制剂;在多发性骨髓瘤模型中显示出功效。
-
Ischemin sodium
一种细胞渗透性 CBP 溴结构域抑制剂,Kd 为 19 uM。
-
XDM-CBP
一种高效、选择性的 CBP/p300 溴结构域抑制剂,Kd 分别为 0.23/0.47 uM。